Investor Murad stated that the crypto bull cycle has not yet begun, even as Bitcoin trades near $82,000 and U.S. spot Bitcoin ETFs saw $526.7 million in inflows on October 19. Despite this inflow reducing October's net outflows to $88 million, data from Glassnode shows continued selling pressure and weak spot demand. Historical analysis from Binance Research suggests that rebounds after shallow drawdowns often fail to sustain new highs, indicating caution. While some analysts see potential for a strong bull cycle, the market remains uncertain with mixed signals from futures, options, and ETF flows.
The crypto bull cycle and Bitcoin's price near $82K provide context for Pluang's market data. For readers following cryptocurrency, here is Pluang's market snapshot as of Oct 21, 2026 02:31 WIB: out of 50 major cryptocurrencies, 44 rose and 5 fell today. Notable movers include COTI at Rp201 (+5.44%), AXS at Rp18,925 (+5.20%), and VET at Rp126 (+4.80%).
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
Brunello Cucinelli, an Italian luxury fashion company, raised its 2026 outlook following stronger-than-expected third-quarter sales. Citigroup maintains a Buy rating on the stock, which trades around $9.43 with a market cap of approximately $6.41 bil...
